Education
About Us
Working with TipRanks
Follow Us
Giant Biogene Holding Co. Ltd. (HK:2367)
:2367
2367 Stock Chart & Stats
HK$35.48
HK$0.10(0.22%)
At close: 4:00 PM EST
HK$35.48
HK$0.10(0.22%)
Day’s Range― - ―
52-Week RangeHK$34.04 - HK$87.10
Previous CloseN/A
Volume2.50M
Average Volume (3M)12.22M
Market Cap
HK$37.52B
Enterprise ValueHK$50.85B
Total Cash (Recent Filing)HK$8.86B
Total Debt (Recent Filing)HK$6.95M
Price to Earnings (P/E)14.9
Beta1.19
Next Earnings
Mar 30, 2026EPS Estimate
1.25Next Dividend Ex-DateN/A
Dividend Yield1.86%
Share Statistics
EPS (TTM)1.24
Shares Outstanding1,070,904,000
10 Day Avg. Volume16,417,830
30 Day Avg. Volume12,220,358
Financial Highlights & Ratios
PEG Ratio0.56
Price to Book (P/B)6.60
Price to Sales (P/S)8.47
P/FCF Ratio26.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$53.68Price Target Upside51.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Future Sales PotentialExpecting influencer live-streaming recovery, which should further boost online sales.
Revenue GrowthResilient revenue growth driven by multiple channels and dual brands.
Sales PerformanceSales growth on JD accelerated significantly, as evidenced by a 134% YoY increase in direct-to-platform e-commerce sales.
Bears Say
Channel PerformanceOffline channel contraction continues to drag Collgene’s overall growth.
Product ApprovalDespite approval delays for certain injectable products, Giant Biogene is well-positioned for long-term growth in the medical aesthetics market.
Profit MarginThe increase in revenue proportion of skincare products led to a decline in GPM from 83.6% to 82.1%.
Giant Biogene Holding Co. Ltd. News
2367 FAQ
What was Giant Biogene Holding Co. Ltd.’s price range in the past 12 months?
Giant Biogene Holding Co. Ltd. lowest stock price was HK$34.04 and its highest was HK$87.10 in the past 12 months.
What is Giant Biogene Holding Co. Ltd.’s market cap?
Giant Biogene Holding Co. Ltd.’s market cap is HK$37.52B.
When is Giant Biogene Holding Co. Ltd.’s upcoming earnings report date?
Giant Biogene Holding Co. Ltd.’s upcoming earnings report date is Mar 30, 2026 which is in 97 days.
How were Giant Biogene Holding Co. Ltd.’s earnings last quarter?
Giant Biogene Holding Co. Ltd. released its earnings results on Aug 27, 2025. The company reported HK$1.237 earnings per share for the quarter, the consensus estimate of HK$1.237 by HK$0.
Is Giant Biogene Holding Co. Ltd. overvalued?
According to Wall Street analysts Giant Biogene Holding Co. Ltd.’s price is currently Undervalued.
Does Giant Biogene Holding Co. Ltd. pay dividends?
Giant Biogene Holding Co. Ltd. pays a Notavailable dividend of HK$1.306 which represents an annual dividend yield of 1.86%. See more information on Giant Biogene Holding Co. Ltd. dividends here
What is Giant Biogene Holding Co. Ltd.’s EPS estimate?
Giant Biogene Holding Co. Ltd.’s EPS estimate is 1.25.
How many shares outstanding does Giant Biogene Holding Co. Ltd. have?
Giant Biogene Holding Co. Ltd. has 1,070,904,000 shares outstanding.
What happened to Giant Biogene Holding Co. Ltd.’s price movement after its last earnings report?
Giant Biogene Holding Co. Ltd. reported an EPS of HK$1.237 in its last earnings report, expectations of HK$1.237. Following the earnings report the stock price went down -5.268%.
Which hedge fund is a major shareholder of Giant Biogene Holding Co. Ltd.?
Currently, no hedge funds are holding shares in HK:2367
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Giant Biogene Holding Co. Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.25%
12-Months-Change
Fundamentals
Return on Equity
29.64%
Trailing 12-Months
Asset Growth
47.89%
Trailing 12-Months
Company Description
Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co. Ltd. (2367) is a biotechnology company based in Hong Kong, specializing in the research, development, and commercialization of innovative healthcare products. The company operates primarily in the biopharmaceutical sector, focusing on the development of biogeneric drugs and therapeutic solutions. With a strong emphasis on cutting-edge biotechnology and biosimilars, Giant Biogene aims to enhance patient care and improve healthcare outcomes through its diverse portfolio of products.
2367 Stock 12 Month Forecast
Average Price Target
HK$53.68
▲(51.30% Upside)
Technical Analysis
Hengan International Group Co
―
Natural Beauty Bio-Technology
―
Cheerwin Group Limited
―
Shanghai Chicmax Cosmetics Co., Ltd. Class H
―
Blue Moon Group Holdings Ltd.
―
Options Prices
Currently, No data available
---